Several TB vaccines are currently in various stages of clinical development, including MIP, VPM1002, MTBVAC, GamTBvac, BCG (re)vaccination, M72/AS01E, DAR-901, H56:IC31, ID93/GLA-SE, RUTI, ChAdOx1.85A +MVA85A, and AEC/BC02, BNT164, TB/FLU-05E, TB/FLU-01L, TB/FLU-04L, and AdHu5Ag85A. Here, MIP is linked to tuberculosis.